Kristy Carroll
Family · Huntsville, TXNPI 1609960343
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AstraZeneca at 26.0% of the total.
Across 156 payments — averaging $20.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$851
- AbbVie$549
- Biohaven Pharmaceuticals, Inc.$381
- Novo Nordisk$298
- Pfizer$270
- Lilly USA, LLC$239
- plus $686 from 21 others
What the payments were for
- Food & beverage$3,24999%
- Education$261%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 24 | $851 |
| AbbVie | 26 | $549 |
| Biohaven Pharmaceuticals, Inc. | 26 | $381 |
| Novo Nordisk | 21 | $298 |
| Pfizer | 13 | $270 |
| Lilly USA, LLC | 8 | $239 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $87 |
| Amgen | 5 | $80 |
| Astellas Pharma US Inc | 3 | $62 |
| Paratek Pharmaceuticals, Inc. | 3 | $60 |
| Amarin Pharma, Inc. | 3 | $57 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Corcept Therapeutics | 1 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Abbott | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Scilex Pharmaceuticals Inc. | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| SK Life Science, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Scynexis, Inc. | 1 | $16 |
| Viatris Specialty LLC | 1 | $15 |
| Medtronic | 1 | $14 |
| GSK | 1 | $13 |
| Genentech USA, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,275 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 54 | $2,587 |
| Testosterone Cypionate | 14 | $1,534 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 137 | $1,435 |
| Alprazolam | 174 | $855 |
| Temazepam | 84 | $854 |
| Clonazepam | 91 | $786 |
| Tramadol Hcl | 116 | $766 |
| Zolpidem Tartrate | 111 | $653 |
| Lorazepam | 73 | $307 |
| Diazepam | 26 | $159 |
Paid to pharmacies, not to this prescriber.
Other family in Huntsville
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.